The value and importance of diagnostics in healthcare have been brought into sharp focus by the Covid 19 pandemic. In the UK, strong partnerships between industry, NHS and government have enabled us to to rapidly expand our diagnostic capacity to respond to this challenge. Building on his capacity will help to provide a path out of the current pandemic and provide resilience against future disease outbreaks.
While Covid 19 has raised the profile of IVDs particularly, the entire spectrum of diagnostic technologies have the potential to improve patient outcomes across a wide range of illnesses. Whether applied in general examination, screening, ruling specific diseases in or out, staging disease progress or monitoring, all diagnostic modalities vital to our future health well-being.
The growth in precision medicine and importance of companion diagnostics, along with both a health system and consumer-led focus on preventative medicine and early detection of disease, has promoted extensive innovation especially relating to the digital enabling of diagnostics and monitoring technologies.
This shows the strength of our industry and we invite you to explore more in our Magnificent Seven Offer.
